July 15, 2025

PACS Group, Inc. (PACS) Stock Analysis: Healthcare Innovator with a 136% Potential Upside

PACS Group, Inc. (PACS), a key player in the healthcare sector, has captured investor attention with its impressive growth metrics and significant potential upside. Based in Farmington, Utah, PACS operates..

Artivion, Inc. (AORT) Stock Analysis: A Medical Device Innovator with a 3.26% Potential Upside

Artivion, Inc. (NASDAQ: AORT), a prominent player in the healthcare sector, specifically within the medical devices industry, showcases a promising investment opportunity. With its headquarters in Kennesaw, Georgia, Artivion’s market..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Exploring a 19.71% Potential Upside Amidst Strong Buy Ratings

Establishment Labs Holdings Inc (NASDAQ: ESTA), a prominent player in the healthcare sector, is gaining attention in the medical devices industry for its innovative approach to aesthetic and reconstructive plastic..

Harrow, Inc. (HROW) Stock Analysis: Eyeing a 59.70% Upside in the Pharmaceutical Sector

Harrow, Inc. (NASDAQ: HROW) stands out in the healthcare sector, particularly among drug manufacturers specializing in specialty and generic pharmaceuticals. With a market capitalization of $1.31 billion, this Nashville-based company..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 43.68% Potential Upside in the Diagnostics & Research Sector

Neogen Corporation (NASDAQ: NEOG), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, offers a unique investment opportunity. With a market capitalization of $1.13 billion,..

Evolent Health, Inc (EVH) Stock Analysis: A 32% Potential Upside and Strong Buy Ratings

Evolent Health, Inc (EVH) stands out in the healthcare sector as a prominent player in the health information services industry. With a market capitalization of $1.33 billion, the company’s focus..

Disc Medicine, Inc. (IRON) Stock Analysis: Unpacking a 70% Upside Potential Amid Biotech Breakthroughs

Disc Medicine, Inc. (NASDAQ: IRON), a prominent player in the biotechnology sector, is capturing investor attention with its compelling potential upside of 70.20%, as indicated by recent analyst ratings. With..

Adaptive Biotechnologies Corporation (ADPT) Stock Analysis: Decoding the Upside in a Dynamic Biotechnology Space

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a prominent player in the biotechnology sector, is capturing investor attention with its innovative immune medicine platform. Boasting a market capitalization of $1.75 billion, the..

NeoGenomics, Inc. (NEO) Stock Analysis: Navigating the Diagnostics Market with 56.69% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO) stands as a significant player in the healthcare sector, specializing in diagnostics and research, with a primary focus on cancer-related testing services. Headquartered in Fort Myers,..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Uncovering a Promising 78.77% Upside Potential

Investors eyeing the healthcare sector may want to take a closer look at ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a biotechnology company that has recently caught the attention of analysts and..

MannKind Corporation (MNKD) Stock Analysis: Unveiling a Promising 133.96% Potential Upside

MannKind Corporation (NASDAQ: MNKD) is drawing significant interest from investors in the biotechnology sector, thanks to its promising therapeutic products for endocrine and orphan lung diseases. With a market capitalization..

Wave Life Sciences Ltd. (WVE) Stock Analysis: A 160% Potential Upside Awaits

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based biotechnology company, is currently drawing significant attention from investors due to its promising potential upside. Specializing in the innovative field of RNA..

agilon health, inc. (AGL) Investor Outlook: Exploring a Potential 89% Upside in the Healthcare Sector

agilon health, inc. (NYSE: AGL), a key player in the medical care facilities industry, is attracting attention from investors with its unique business model tailored to the healthcare needs of..

Certara, Inc. (CERT) Stock Analysis: Exploring a 41.63% Potential Upside

Certara, Inc. (CERT), a key player in the healthcare sector specializing in health information services, is drawing renewed attention from investors due to its promising upward potential. With a market..

Aurinia Pharmaceuticals Inc (AUPH): Investor Outlook with a 10.62% Potential Upside and Strong Buy Ratings

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has been making waves in the biotechnology sector, drawing attention with its strong market presence and promising financial metrics. As a Canada-based biopharmaceutical company, Aurinia..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring a Promising 58.98% Potential Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is making waves in the biotechnology sector with its innovative approach to treating eye conditions. With a market capitalization of $1.8 billion, this Bedford, Massachusetts-based..

Integra LifeSciences Holdings C (IART) Stock Analysis: Assessing the 32% Potential Upside

Integra LifeSciences Holdings Corporation (IART), a key player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors looking at the medical device industry. With a..

Novavax, Inc. (NVAX) Investor Outlook: Exploring a Potential 92.66% Upside

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, has captured investor attention with its innovative approach to vaccine development. Specializing in recombinant protein vaccines, Novavax has been..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Gem with a 95.72% Upside Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a promising player in the biotechnology sector headquartered in Naarden, the Netherlands, is capturing investor attention with its robust pipeline and substantial growth potential...

89bio, Inc. (ETNB) Stock Analysis: Exploring a 164.88% Potential Upside in Biotech Innovation

Investors seeking high-growth opportunities in the biotech sector may find 89bio, Inc. (NASDAQ: ETNB) an intriguing prospect. With a current market capitalization of $1.62 billion, this clinical-stage biopharmaceutical company is..

Search

Funds

July 15, 2025

Search

Funds

July 15, 2025

FTSE 100

Funds